Press releases

Six pre-selected strains are in the testing phase to validate the final choice of the active ingredient to be marketed in 2018. Technology...

This active ingredient with proven antioxidant and healing properties is an innovative carotenoid produced by Deinococcus bacteria. The...

Cash position: +€6.6m at June 30, 2017 compared to +€9.3m at December 31, 2016. Half-year net loss of DEINOVE Group (composed of DEINOVE...

Sébastien Enault brings to the Company a proven track record in the development of collaborations in the pharmaceutical field and, in...

Phase I of the program selected the first carotenoid molecule to be produced on an industrial scale in 2018. The yields obtained in 20-...

PhD in molecular pharmacology, expert in the development of new molecules and their formulation, Dr. Gaudriault has spent his entire career...

Hervé Brailly, co-founder and executive of Innate Pharma SA [IPH], one of the world's leading immuno-oncology specialists and one of the...

Focuses on the use of Deinococcus as a source of feed ingredients Issued in China, the world's leading country for livestock farming...